SERPLANO

Serial Number 90154210
606

Registration Progress

Application Filed
Sep 2, 2020
Under Examination
Mar 9, 2021
Approved for Publication
Jan 12, 2021
Published for Opposition
Jan 12, 2021
Registered

Trademark Image

SERPLANO

Basic Information

Serial Number
90154210
Filing Date
September 2, 2020
Published for Opposition
January 12, 2021
Abandonment Date
April 15, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Apr 15, 2024
Classes
005

Rights Holder

JOHNSON & JOHNSON

03
Address
One Johnson & Johnson Plaza
New Brunswick, NJ 08933

Ownership History

JOHNSON & JOHNSON

Original Applicant
03
New Brunswick, NJ

JOHNSON & JOHNSON

Owner at Publication
03
New Brunswick, NJ

Legal Representation

Attorney
Danielle R. Weitzman

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

34 events
Date Code Type Description Documents
Apr 15, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Apr 15, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Sep 15, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 14, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
Sep 14, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 6, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Sep 6, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 3, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 1, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Mar 1, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Mar 1, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 17, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 17, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 17, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 19, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 17, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 17, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 17, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 9, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 7, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 7, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 7, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 19, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 17, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 17, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 17, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 9, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 12, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 12, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 23, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 3, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 2, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 7, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 5, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Classification

International Classes
005